rs762213305

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BA1BP4

This summary comes from the ClinGen Evidence Repository: The NM_001754.4:c.1396A>T variant that results in a Met466Leu missense change has an MAF of 0.001761 (0.1%, 23/13058 alleles) in the East Asian subpopulation of the gnomAD v2.1.1 cohort, which is >0.0015 (0.15%) (BA1). This missense variant has a REVEL score <0.15 (0.149) and SSF and MES predict no effect on splicing (BP4). The variant has not been reported in the germ line of patients with familial platelet disorder with predisposition to hematologic malignancies in the literature, to the best of our knowledge. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BA1, BP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10014176/MONDO:0011071/008

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000020 ( 0 hom. )

Consequence

RUNX1
NM_001754.5 missense

Scores

1
3
14

Clinical Significance

Benign reviewed by expert panel U:1B:4

Conservation

PhyloP100: 2.86

Publications

7 publications found
Variant links:
Genes affected
RUNX1 (HGNC:10471): (RUNX family transcription factor 1) Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
RUNX1 Gene-Disease associations (from GenCC):
  • hereditary thrombocytopenia and hematologic cancer predisposition syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001754.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RUNX1
NM_001754.5
MANE Select
c.1396A>Tp.Met466Leu
missense
Exon 9 of 9NP_001745.2
RUNX1
NM_001001890.3
c.1315A>Tp.Met439Leu
missense
Exon 6 of 6NP_001001890.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RUNX1
ENST00000675419.1
MANE Select
c.1396A>Tp.Met466Leu
missense
Exon 9 of 9ENSP00000501943.1
RUNX1
ENST00000300305.7
TSL:1
c.1396A>Tp.Met466Leu
missense
Exon 8 of 8ENSP00000300305.3
RUNX1
ENST00000344691.8
TSL:1
c.1315A>Tp.Met439Leu
missense
Exon 6 of 6ENSP00000340690.4

Frequencies

GnomAD3 genomes
AF:
0.0000265
AC:
4
AN:
151094
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000783
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000162
AC:
22
AN:
135870
AF XY:
0.000149
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00191
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000203
AC:
28
AN:
1379136
Hom.:
0
Cov.:
32
AF XY:
0.0000176
AC XY:
12
AN XY:
681080
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31312
American (AMR)
AF:
0.00
AC:
0
AN:
36048
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24494
East Asian (EAS)
AF:
0.000723
AC:
26
AN:
35984
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78342
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33550
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4712
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1077284
Other (OTH)
AF:
0.0000348
AC:
2
AN:
57410
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000265
AC:
4
AN:
151216
Hom.:
0
Cov.:
32
AF XY:
0.0000271
AC XY:
2
AN XY:
73914
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41384
American (AMR)
AF:
0.00
AC:
0
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.000786
AC:
4
AN:
5092
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4776
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10336
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67632
Other (OTH)
AF:
0.00
AC:
0
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000793
ExAC
AF:
0.0000635
AC:
7

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 (2)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
18
DANN
Benign
0.93
DEOGEN2
Benign
0.30
T
Eigen
Benign
0.13
Eigen_PC
Benign
0.18
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.88
D
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.0090
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.86
L
PhyloP100
2.9
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-0.42
N
REVEL
Benign
0.15
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.70
P
Vest4
0.19
MutPred
0.62
Loss of catalytic residue at M439 (P = 0.0082)
MVP
0.39
MPC
1.5
ClinPred
0.14
T
GERP RS
4.7
Varity_R
0.46
gMVP
0.28
Mutation Taster
=68/32
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs762213305; hg19: chr21-36164479; API